Health plans and payers have plenty of options for how to analyze the effectiveness of digital therapeutic tools, as there are several effective strategies, according to Soumya Vishwanath, PharmD, of Magellan Rx Management.
Health plans and payers have plenty of options for how to analyze the effectiveness of digital therapeutic tools as there are several effective strategies, according to Soumya Vishwanath, PharmD, senior manager of Formulary Management at Magellan Rx Management, at the Academy of Managed Care Pharmacy's annual meeting.
Transcript
What are some of the different strategies that health systems have implemented to assess the effectiveness of digital therapeutic tools?
Some of the strategies that some health plans and payers have implemented are creating an objective criteria on how to review digital therapeutics products based on priorities that are important to them. So, recognizing what's the scope that they want to evaluate; whether it's digital health, digital medicine, digital therapeutics, or a scope in a specific disease state. That's a great objective start to reviewing and evaluating these products and understanding whether it would serve their patient population and be appropriate for their formulary.
An Elevated Member Experience, More Education, and Martha Stewart at the AAD 2025 Annual Meeting
March 4th 2025Seemal R Desai, MD, FAAD, president of the American Academy of Dermatology (AAD), emphasized his commitment to enhancing the upcoming 2025 annual meeting by introducing new events and expanding educational offerings to better serve and engage members.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
NSCLC Advancements Offer Hope, but Disparities Persist
February 20th 2025Ioana Bonta, MD, Georgia Cancer Specialists, discusses the evolving state of non-small cell lung cancer (NSCLC) treatments, their impact on patient outcomes, and the need to address ongoing disparities in these populations.
Read More
Understanding TB Symptoms, Spread, Treatment Amid Kansas City Outbreak
February 13th 2025In part 2 of this interview, Michael A. Bernstein, MD, highlights the need for prolonged antibiotics and strong public health measures to combat tuberculosis (TB) at both the individual and population levels.
Read More